1. SK Chemicals Q2 Earnings: Key Highlights

SK Chemicals held its Q2 2025 earnings announcement and management briefing on August 8th. The primary focus of this IR was the continued growth of the Green Chemicals and Life Science businesses, the strategic direction of SK bioscience’s CDMO business, and strategies for navigating the macroeconomic environment.

2. Growth Drivers and Risks by Business Segment

2.1 Green Chemicals: Leading the Eco-Friendly Materials Market

  • Positive Factors: Expanding market for eco-friendly materials (bio-polyols, recycled PET), strengthening market dominance in copolyester resins.
  • Risks: Dependence on the Chinese market and intensifying competition, volatility of raw material prices.

2.2 Life Science: Growth Potential of SK bioscience

  • Positive Factors: Expansion of SK bioscience’s CDMO business, stable pharmaceutical and vaccine portfolio.
  • Risks: Investment burden of SK bioscience, intensifying competition in the CDMO market.

3. SK Chemicals Investment Strategy: Key Points

When investing in SK Chemicals, closely monitor Q2 earnings, the turnaround timing and plans for SK bioscience, and strategies for responding to the macroeconomic environment. The growth of the Green Chemicals business and the improvement in profitability of SK bioscience’s CDMO business will be important indicators for investment decisions.

4. Conclusion: Long-Term Growth Outlook, Short-Term Volatility Caution

SK Chemicals holds long-term growth potential, centered around its Green Chemicals and Life Science businesses. However, macroeconomic uncertainties and the investment burden of SK bioscience may cause short-term stock price volatility. Investors should make cautious investment decisions by comprehensively considering the IR announcements and market conditions.